QQ客服 官方微博 反馈留言

浏览/检索结果: 共20条，第1-10条 帮助 限定条件 发表日期：2020     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Determination of the antidiabetic chemical basis of Phellodendri Chinensis Cortex by integrating hepatic disposition in vivo and hepatic gluconeogenese inhibition in vitro 期刊论文 JOURNAL OF ETHNOPHARMACOLOGY, 2020, 卷号: 263, 页码: 10 作者:  Tian, Xiaoting;  Xu, Zhou;  Hu, Pei;  Yu, Yanyan;  Li, Zhixiong 收藏  |  浏览/下载：74/0  |  提交时间：2020/12/21 Phellodendri Chinensis cortex  Hepatic disposition  Pharmacokinetics  Berberine  Metabolites  Hepatic gluconeogenesis   High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo 期刊论文 BIOACTIVE MATERIALS, 2020, 卷号: 5, 期号: 4, 页码: 779-786 作者:  Chen, Shanshan;  Yao, Zhifeng;  Guan, Yongbiao;  Yang, Hui;  Shahzad, M. Babar 收藏  |  浏览/下载：44/0  |  提交时间：2021/02/02 Sirolimus-eluting stent  Pharmacokinetics  Preclinical safety  Tissue response   Pharmacokinetics, mass balance, and metabolism of [C-14]vicagrel, a novel irreversible P2Y(12) inhibitor in humans 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Zheng, Yuan-dong;  Zhang, Hua;  Zhan, Yan;  Bian, Yi-cong;  Ma, Sheng 收藏  |  浏览/下载：44/0  |  提交时间：2021/05/24 vicagrel  [C-14]vicagrel  vicagrel pharmacokinetics  vicagrel metabolism  mass balance  P2Y(12) receptor inhibitor   Mechanism and optimization of supramolecular complexation-enhanced fluorescence spectroscopy for the determination of SN-38 in plasma and cells 期刊论文 LUMINESCENCE, 2020, 页码: 12 作者:  Zhao, Kena;  Guo, Tao;  Sun, Xian;  Xiong, Ting;  Ren, Xiaohong 收藏  |  浏览/下载：48/0  |  提交时间：2020/12/24 cyclodextrins  inclusion complex  pharmacokinetics  SN‐  38  spectrofluorimetric  transfer   Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 6 作者:  Hu, Wen-juan;  Chang, Lu;  Yang, Ying;  Wang, Xin;  Xie, Yuan-chao 收藏  |  浏览/下载：51/0  |  提交时间：2020/12/21 remdesivir  pharmacokinetics  tissue distribution  nucleotide monophosphate  nucleotide triphosphate  nucleoside   Sulfation predominates the pharmacokinetics, metabolism, and excretion of forsythin in humans: major enzymes and transporters identified 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Pan, Lu-lu;  Yang, Yong;  Hui, Min;  Wang, Shuo;  Li, Cui-yun 收藏  |  浏览/下载：84/0  |  提交时间：2020/12/24 forsythin  pharmacokinetics  drug metabolism  drug excretion  sulfation  glucuronidation  organic anion transporter 3   Repurposing of Kinase Inhibitors for Treatment of COVID-19 期刊论文 PHARMACEUTICAL RESEARCH, 2020, 卷号: 37 作者:  Weisberg, Ellen;  Parent, Alexander;  Yang, Priscilla L.;  Sattler, Martin;  Liu, Qingsong 收藏  |  浏览/下载：34/0  |  提交时间：2020/10/26 Coronavirus  SARS-CoV-2  SARS-CoV  MERS-CoV  kinase inhibitors  pharmacokinetics  antiviral therapy  COVID-19   Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9 作者:  Tian, Qian-qian;  Zhu, Yun-ting;  Diao, Xing-xing;  Zhang, Xiang-lei;  Xu, Ye-chun 收藏  |  浏览/下载：70/0  |  提交时间：2020/12/24 PDE5 inhibitor  TPN729  M3  species difference  pharmacokinetics  metabolite identification   Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2020, 卷号: 32, 期号: 3, 页码: 370-+ 作者:  Li, Huiping;  Liu, Rongrui;  Shao, Bin;  Ran, Ran;  Song, Guohong 收藏  |  浏览/下载：22/0  |  提交时间：2020/12/24 Phase I  PARP inhibitor (fluzoparib)  solid tumor  pharmacokinetics  safety  antitumor activity   Enhanced oral bioavailability and bioefficacy of phloretin using mixed polymeric modified self-nanoemulsions 期刊论文 FOOD SCIENCE & NUTRITION, 2020, 页码: 14 作者:  Wang, Yiling;  Li, Dongli;  Lin, Huiqiong;  Jiang, Sen;  Han, Lei 收藏  |  浏览/下载：140/0  |  提交时间：2020/07/01 anti-inflammatory  bioavailability  pharmacokinetics  phloretin  self-nanoemulsions  solubility